Synthetic Bone Graft Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Synthetic Bone Graft Substitutes Pipeline Market Report Overview
Synthetic bone graft substitutes are used as substitutes to autograft and allograft bone. Major types of synthetic bone substitutes include calcium sulfate, calcium phosphate, tricalcium phosphate (TCP), and coralline hydroxyapatite. The second-generation products include bioactive glass, collagen-containing and polymer-based bone substitutes. Products available in the form of granules, paste, pellets or strips are all tracked here. One unit volume is 10ml of synthetic bone substitutes.
The synthetic bone graft substitutes pipeline market research report provides comprehensive information about the synthetic bone graft substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
| Key Territories | The US, Europe, China, Japan, and Taiwan |
| Key Regulatory Paths | 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo |
| Leading Companies | Acuitive Technologies Inc, Agenta Biotechnologies Inc (Inactive), Amend Surgical, Inc., Anika Therapeutics Inc, Baxter International Inc, Berkeley Advanced Biomaterials Inc, Bio2 Technologies Inc, BioGend Therapeutics Co Ltd, Biomatlante SA, Biorez Inc, and BonAlive Biomaterials Ltd |
Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Territories
Some of the territories in the synthetic bone graft substitutes pipeline market are the US, Europe, China, Japan, and Taiwan among others. As of May 2023, the US has the highest number of pipeline products.
Synthetic Bone Graft Substitutes Pipeline Market Analysis, by Territories, 2023 (%)
For more territory insights into the synthetic bone graft substitutes pipeline market, download a free report sample
Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Regulatory Paths
Some of the regulatory paths in the synthetic bone graft substitutes pipeline market are 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo among others. As of May 2023, 510(k) is the most followed pathway for pipeline products.
Synthetic Bone Graft Substitutes Pipeline Market Analysis, by Regulatory Paths, 2023 (%)
For more regulatory path insights into the synthetic bone graft substitutes pipeline market, download a free report sample
Synthetic Bone Graft Substitutes Pipeline Market – Competitive Landscape
Some of the key companies in the synthetic bone graft substitutes pipeline market are Acuitive Technologies Inc, Agenta Biotechnologies Inc (Inactive), Amend Surgical, Inc., Anika Therapeutics Inc, Baxter International Inc, Berkeley Advanced Biomaterials Inc, Bio2 Technologies Inc, BioGend Therapeutics Co Ltd, Biomatlante SA, Biorez Inc, and BonAlive Biomaterials Ltd among others.
Acuitive Technologies Inc: Acuitive Technologies Inc (Acuitive Technologies) is a developer of surgical medical devices designed to help in surgeries. It is headquartered in Allendale, New Jersey, the US. Citrefoam is developed by Acuitive Technologies. It is a synthetic porous sponge intended for bone healing. It is designed to fill bone voids of various sizes and promote bone healing. It is based on CITREGEN Technology.
Segments Covered in the Report
Synthetic Bone Graft Substitutes Pipeline Market Territories Outlook
- The US
- Europe
- China
- Japan
- Australia
- Taiwan
Synthetic Bone Graft Substitutes Pipeline Market Regulatory Paths Outlook
- 510(k)
- PMA
- CE
- NMPA
- TGA
- Ninsho
- De Novo
Scope
- Extensive coverage of the synthetic bone graft substitutes under development
- Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- Reviews the major players involved in the development of synthetic bone graft substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of synthetic bone graft substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Agenta Biotechnologies Inc (Inactive)
Amend Surgical, Inc.
Anika Therapeutics Inc
Baxter International Inc
Berkeley Advanced Biomaterials Inc
Bio2 Technologies Inc
BioGend Therapeutics Co Ltd
Biomatlante SA
Biorez Inc
BonAlive Biomaterials Ltd.
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Calcitec, Inc.
Daewoong Pharmaceutical Co Ltd
Dimension Inx LLC
DSM Biomedical BV
Elute Inc
Eskisehir Osmangazi University
EternoGen Aesthetics LLC
Graftys SA
Industrie Biomediche Insubri SA
Innovoss Inc. (Inactive)
IRCCS San Raffaele Hospital
Isto Biologics
King's College London
Maxigen Biotech Inc
National Center of Innovation for Biomaterials in Orthopaedic Research
National University of Science and Technology MiSiS
OrthoMedex LLC
PolyPid Ltd
Polytechnic University of Catalonia
Promimic AB
ReCaPP
RepRegen Ltd. (Inactive)
Revivicor Inc
Sanara MedTech Inc
Scil Technology GmbH
SDIP Innovations Pty Ltd
SIRAKOSS Ltd
Sofregen Medical Inc
Soteira Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
SurGenTec LLC
University of California San Diego
University of Edinburgh
Wright Medical Group NV (Inactive)
Xtant Medical Holdings Inc
Table of Contents
Frequently asked questions
-
Which territory has the highest number of pipeline products in the synthetic bone graft substitutes pipeline market as of May 2023?
As of May 2023, the US has the highest number of pipeline products in the synthetic bone graft substitutes pipeline market.
-
Which is the most followed regulatory pathway in the synthetic bone graft substitutes pipeline market As of May 2023?
As of May 2023, 510(k) is the most followed regulatory pathway in the synthetic bone graft substitutes pipeline market.
-
Who are the major players operating in the synthetic bone graft substitutes pipeline market?
Some of the major players operating in the synthetic bone graft substitutes pipeline market are Acuitive Technologies Inc, Agenta Biotechnologies Inc (Inactive), Amend Surgical, Inc., Anika Therapeutics Inc, Baxter International Inc, Berkeley Advanced Biomaterials Inc, Bio2 Technologies Inc, BioGend Therapeutics Co Ltd, Biomatlante SA, Biorez Inc, and BonAlive Biomaterials Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Synthetic Bone Graft Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
